3dheals

3dheals Healthcare 3D Printing Ecosystem and Innovation Platform, SF based company, focusing on curating high https://linktr.ee/3dheals

🔬 Speaker spotlight: Dr. Pranav Joshi, Senior Scientist at Bioprinting Laboratories Inc.Pranav develops and validates hu...
08/31/2026

🔬 Speaker spotlight: Dr. Pranav Joshi, Senior Scientist at Bioprinting Laboratories Inc.

Pranav develops and validates human iPSC-derived brain and liver organoid platforms for predictive toxicology and NAMs — spanning 3D bioprinting, perfusion culture, and scalable, assay-ready deployment via microarrays. His team's "Human Brain Organoids to Predict DNT" project was a Phase 1 winner of the NIH Complement-ARIE NAMs challenge. If you care about organoid standardization and fit-for-purpose validation, this is your talk.

Join us Aug 20 for New Approach Methodologies: From Theory to Validation.
👉 Register: https://3dheals.com/new-approach-methodologies-from-theory-to-validation/

🔬 Speaker spotlight: Graham Craig, Chief Commercial Officer at VoxCell.VoxCell is building high-resolution, vascularized...
08/31/2026

🔬 Speaker spotlight: Graham Craig, Chief Commercial Officer at VoxCell.

VoxCell is building high-resolution, vascularized 3D tissue models as NAMs for drug development. Graham leads their commercial strategy and global partnerships — putting human-relevant preclinical models into the hands of pharma, CROs, and research teams so they can generate decision-enabling data earlier and lean less on animal testing. With 18+ years across AbCellera, STEMCELL Technologies, and IQVIA, he knows how these platforms cross from lab to market.

Catch him at New Approach Methodologies: From Theory to Validation — Aug 20.
👉 Register: https://3dheals.com/new-approach-methodologies-from-theory-to-validation/

🎙️ Moderator spotlight: Lowry Curley, founder of Luna LifeSci.Lowry built AxoSim (now 28bio) from a Tulane spinout into ...
08/31/2026

🎙️ Moderator spotlight: Lowry Curley, founder of Luna LifeSci.

Lowry built AxoSim (now 28bio) from a Tulane spinout into a venture-backed neural microphysiological-systems company serving nearly every top-25 global pharma — the full arc from early research to a validated, human-relevant platform, plus two acquisitions along the way. Today, through Luna LifeSci, he helps pharma and biotech adopt NAMs in their preclinical programs. The perfect guide for a conversation from theory to validation.

Join us Aug 20.
👉 Register: https://3dheals.com/new-approach-methodologies-from-theory-to-validation/

This week in The Lattice Brief: a better 3D-printed stent is the easy part. Getting paid is the hard part. https://mail...
08/31/2026

This week in The Lattice Brief: a better 3D-printed stent is the easy part. Getting paid is the hard part. https://mailchi.mp/3dheals/the-lattice-brief-august-30th

Also in the issue:
- Madrid's Gregorio Maranon prints a metamaterial bone implant in-house and saves a sarcoma patient's leg
- New bioprinting: suturable vascular grafts and self-aligning skeletal muscle
- From 3DHEALS: our Biomaterials Frontier panel on September 10

Read this week's brief and subscribe: https://mailchi.mp/3dheals/signup

Address

901 Mission Street #105
San Francisco, CA
94103

Telephone

+14156245881

Website

Alerts

Be the first to know and let us send you an email when 3dheals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The School

Send a message to 3dheals:

Shortcuts

Share

Category